Contents

Recent Patents on Anti-Cancer Drug Discovery, Volume 2 - Number 2

The Anti-Cancer Charm of Flavonoids: A Cup-of-Tea Will Do!

, 2(2): 109 - 117

Amr Amin and Michael Buratovich


DOI: 10.2174/157489207780832414




Histone Deacetylase Inhibitors: A New Wave of Molecular Targeted Anticancer Agents

, 2(2): 119 - 134

Alfredo Budillon, Elena Di Gennaro, Francesca Bruzzese, Monia Rocco, Giuseppe Manzo and Michele Caraglia


DOI: 10.2174/157489207780832450




Mechanisms to Inhibit Matrix Metalloproteinase Activity: Where are we in the Development of Clinically Relevant Inhibitors?

, 2(2): 135 - 142

Christian A. Corbitt, Jing Lin and Merry L. Lindsey


DOI: 10.2174/157489207780832423




Integrin αvβ3 Antagonists for Anti-Angiogenic Cancer Treatment

, 2(2): 143 - 158

Andrew R. Hsu, Anand Veeravagu, Weibo Cai, Lewis C. Hou, Victor Tse and Xiaoyuan Chen


DOI: 10.2174/157489207780832469




Potential of Alphavirus Vectors in the Treatment of Advanced Solid Tumors

, 2(2): 159 - 166

Barbara J. Kelly, Marina N. Fleeton and Gregory J. Atkins


DOI: 10.2174/157489207780832432




Thalidomide Analogues as Anticancer Drugs

, 2(2): 167 - 174

Jeanny B. Aragon-Ching, Haiqing Li, Erin R. Gardner and William D. Figg


DOI: 10.2174/157489207780832478




Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer

, 2(2): 175 - 186

Constantinos Mikelis, Marina Koutsioumpa and Evangelia Papadimitriou


DOI: 10.2174/157489207780832405




Patent Selections

, 2(2): 187 - 188

Bentham Science Publishers


DOI: 10.2174/157489207780832441




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science